(Q43999027)

28 November 2017

Evolution of hepatic fibrosis research (English)

1 reference

28 November 2017

Norifumi Kawada

1

1 reference

28 November 2017

1 March 2011

1 reference

28 November 2017

1 reference

28 November 2017

41

1 reference

28 November 2017

3

1 reference

28 November 2017

199-208

1 reference

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

28 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Evolving challenges in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Fibrogenic signalling in hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Portal fibroblasts: Underappreciated mediators of biliary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Functional role of chemokines in liver disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Role of host genetics in fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

The niche of stellate cells within rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Adipogenic transcriptional regulation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Extracellular matrix degradation and the role of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00776.X

10.1111/J.1872-034X.2011.00776.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

21338451